Press release
Global Urinalysis Market Forecast to Surpass USD 9 Billion by 2032, estimates DelveInsight
Urinalysis Market
The global urinalysis market is poised for substantial expansion, with its valuation expected to almost double from USD 4,510.55 million in 2024 to approximately USD 9,021.90 million by 2032. This growth reflects a consistent compound annual growth rate (CAGR) of 9.10% throughout the 2025-2032 forecast timeline. The strong upward trajectory is primarily driven by the rising incidence of urinary conditions, including urinary tract infections (UTIs) and chronic kidney disorders, an increase in hospital-acquired infections, and ongoing technological advancements in urinalysis diagnostics.
Urinalysis serves as a vital diagnostic procedure that evaluates urine components to support early identification of urinary tract and renal abnormalities, allowing clinicians to initiate timely and appropriate treatment interventions. Market segmentation analysis highlights significant growth opportunities across various product categories, testing methods, end-user groups, and regional markets, collectively shaping a positive outlook for this essential diagnostic domain.
DelveInsight's Urinalysis Market Insights report delivers a comprehensive overview of current and future market dynamics, including revenue forecasts, market share analysis of leading urinalysis companies, key growth drivers, restraints, emerging trends, and competitive positioning within the global landscape.
Download the free sample report here: Urinalysis Market Forecast [https://www.delveinsight.com/report-store/urinalysis-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=apr]
Urinalysis Market Growth Drivers
One of the primary forces accelerating market growth is the increasing global prevalence of urinary disorders. According to NHS England data from 2023, approximately 147,285 hospital admissions during 2022-2023 were attributed to UTIs. Older adults were particularly impacted, with individuals aged 65 years and above accounting for 56% of these cases, highlighting the pressing need for accurate and efficient diagnostic solutions. The growing burden of UTIs-especially catheter-associated infections within hospital settings-continues to fuel demand for fast and dependable urinalysis technologies that aid clinical decision-making.
In parallel, chronic kidney disease (CKD) is emerging as a major global health concern. Data released by the Australian Bureau of Statistics in 2023 indicate that more than 246,000 Australians are currently living with CKD, reflecting trends observed across both developed and developing regions. Urinalysis plays a crucial role in kidney health monitoring by identifying markers such as hematuria and proteinuria, thereby supporting early intervention, disease management, and preventive care strategies.
Gain in-depth insights into market trends, innovations, and growth prospects. Download your report copy today: Urinalysis Market Dynamics and Trends [https://www.delveinsight.com/sample-request/urinalysis-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=apr]
Technological Advancements Driving the Urinalysis Market
Rapid innovation in diagnostic technologies is significantly contributing to market expansion. The introduction of advanced automated urine analyzers-integrating artificial intelligence (AI), flow cytometry, and cloud-based systems-has transformed laboratory workflows by minimizing manual errors, enhancing efficiency, and improving diagnostic accuracy. For instance, Sysmex Corporation launched the UF-1500 automated particle analyzer in 2022 to boost laboratory productivity. Similarly, Olive Diagnostics introduced the Olive KG, an AI-enabled spectroscopy-based device capable of delivering high-quality urinalysis without the need for consumables or accessories.
These technological breakthroughs are expanding urinalysis testing beyond conventional hospital environments to smaller healthcare facilities and home-based settings, improving access to early diagnostic services. Point-of-care testing (POCT) solutions are witnessing growing adoption due to their ease of use and ability to deliver rapid results, empowering both healthcare professionals and patients.
However, despite technological progress, market growth remains constrained in low-income regions due to limited availability of diagnostic tools and the suboptimal performance of certain UTI test products. Bridging these gaps will be critical to ensuring equitable global market expansion.
Urinalysis Product and Segment Analysis
The urinalysis market is broadly segmented into instruments and consumables. Within the instruments category, automated urine analyzers account for a dominant share and are expected to maintain strong revenue generation from 2024 onward, owing to their enhanced precision, high throughput capabilities, and suitability for large-scale diagnostic settings. These systems support integrated chemical and sediment analysis, making them indispensable in high-volume laboratories.
Consumables-including reagents, testing kits, and related supplies-also represent a vital segment, ensuring continuity of routine diagnostic operations.
Based on testing methodology, biochemical and microscopic urinalysis hold the largest market share, underscoring their critical role in the diagnosis and long-term monitoring of urinary disorders.
From an end-user perspective, the market caters to hospitals and clinics, diagnostic laboratories, home care environments, and other healthcare settings. While hospitals and laboratories remain major consumers, the home care segment is experiencing rapid growth due to increasing health awareness and a rising emphasis on preventive screening.
Explore how the urinalysis market is expected to exceed USD 9 billion by 2032. Access your complimentary sample report today: Urinalysis Market Size and Forecasts [https://www.delveinsight.com/report-store/urinalysis-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=apr]
Urinalysis Regional Outlook: North America Dominates the Urinalysis Market
North America continues to lead the global urinalysis market, holding the largest share in 2024. This dominance is supported by a high incidence of urinary tract and kidney diseases, robust healthcare infrastructure, and early adoption of advanced diagnostic technologies. Additionally, government-led initiatives promoting routine health screenings and early disease detection further strengthen market demand.
In 2023, the United States accounted for nearly 42% of complicated UTI cases across major global markets, with catheter-associated infections representing approximately 75% of hospital-acquired UTIs. These statistics highlight the growing need for scalable and efficient urinalysis solutions within the U.S. healthcare system.
Recent regulatory approvals also reflect ongoing innovation in the region. For example, the FDA clearance of the Alltest Fentanyl Urine Test Cassette in late 2023 introduced an over-the-counter rapid testing solution, expanding the application scope of urine-based diagnostics.
Unlock strategic intelligence in the global urinalysis market - connect with DelveInsight's experts today to access in-depth market insights, emerging opportunities, and data-driven guidance for informed decision-making @ Urinalysis Companies and Approvals [https://www.delveinsight.com/sample-request/urinalysis-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=apr]
Key Companies Operating in the Urinalysis Market
The urinalysis market is highly competitive, with established global healthcare players actively investing in research and development, strategic collaborations, and geographic expansion to strengthen their market presence. Prominent companies operating in this space include F. Hoffmann-La Roche Ltd., Beckman Coulter, Siemens Healthcare, Sysmex Corporation, Abbott, Carolina Liquid Chemistries, Medline Industries, Olive Diagnostics, ACON Laboratories, Arkray Inc., and Mindray Medical International, among others.
Recent strategic initiatives underline the market's dynamic nature. In August 2024, Carolina Liquid Chemistries partnered with Medline to distribute fentanyl screening tests, while in July 2024, Mexple introduced specialized urine collection kits tailored for both male and female patients.
Urinalysis Market Opportunities and Strategic Perspectives
The expanding role of urinalysis in preventive healthcare, coupled with an aging global population and increasing prevalence of chronic diseases, presents significant growth opportunities for industry stakeholders. Emerging economies, in particular, offer untapped potential as healthcare infrastructure improves and awareness of early diagnostics continues to rise.
Manufacturers, investors, research institutions, and healthcare providers can capitalize on this growth by prioritizing innovation, improving affordability, and developing customized solutions that address diverse end-user requirements.
Access competitive intelligence in the rapidly evolving urinalysis market. Connect with DelveInsight's experts for tailored strategic insights: Urinalysis Market Report [https://www.delveinsight.com/sample-request/urinalysis-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=apr]
Who Should Read This Report?
* Manufacturers and distributors of urinalysis products
* Healthcare consulting firms and research organizations
* Medical associations and healthcare policymakers
* Diagnostic-focused startups and venture capital investors
* End-users such as hospitals, clinics, diagnostic laboratories, and home care providers
About the Urinalysis Market Report
This in-depth Urinalysis Market report offers detailed analysis of market size, segment-level forecasts, recent product launches, mergers and acquisitions, and regional growth trends from 2025 to 2032. It also provides insights into leading product categories, high-growth regions, and the competitive strategies adopted by established and emerging players.
About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=global-urinalysis-market-forecast-to-surpass-usd-9-billion-by-2032-estimates-delveinsight]
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/consulting
Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Urinalysis Market Forecast to Surpass USD 9 Billion by 2032, estimates DelveInsight here
News-ID: 4345443 • Views: …
More Releases from ABNewswire
Tendinopathy Market Size in the 7MM is Project to Grow with a Significant CAGR b …
DelveInsight's "Tendonitis Market Insights, Epidemiology, and Market Forecast-2034" report delivers an in-depth understanding of the Tendonitis, historical and forecasted epidemiology as well as the Tendonitis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Discover Key Insights into the Tendinopathy Market with DelveInsight's In-Depth Report @ Tendinopathy Market Size [https://www.delveinsight.com/sample-request/tendinopathy-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Key Takeaways from the Tendonitis Market Research Report
* On January 08, 2026- Laboratorios Silanes S.A.…
Bipolar Disorder Clinical Trial Pipeline Appears Robust With 20+ Key Pharma Comp …
DelveInsight's "Bipolar Disorder Pipeline Insight 2026" report provides comprehensive insights about 20+ companies and 20+ pipeline drugs in the Bipolar Disorder pipeline landscape. It covers the Bipolar Disorder Pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Bipolar Disorder Pipeline Therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Curious about the latest updates…
Pre-Eclampsia Clinical Trial Pipeline Accelerates as 5+ Pharma Companies Rigorou …
DelveInsight's, "Pre-Eclampsia Pipeline Insight 2026" report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Pre-Eclampsia pipeline landscape. It covers the Pre-Eclampsia Pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Pre-Eclampsia Pipeline Therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Curious about the latest updates in the Pre-Eclampsia Pipeline? Click…
Nipocalimab Market Size Forecast and Emerging Insights Signal Strong Growth Outl …
Nipocalimab Overview in approved indications like Myasthenia gravis; as well as potential indications like Fetal erythroblastosis, Neonatal alloimmune thrombocytopenia, Sjogren's syndrome, Systemic lupus erythematosus and others.
The Nipocalimab market is entering a pivotal growth phase, driven by recent regulatory approvals, strong late-stage clinical data, expanding geographic reach, and a robust pipeline of potential label expansions across antibody-mediated diseases. As a next-generation neonatal Fc receptor (FcRn) blocker developed by Johnson & Johnson…
More Releases for Urinalysis
Geriatric Population Surge Fuels Growth In The Urinalysis Market: An Emerging Dr …
The Urinalysis Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Projected Growth of the Urinalysis Market?
The size of the urinalysis market has witnessed significant growth over the last few years. It is projected to rise from a valuation of $3.57 billion in…
Global Urinalysis Strips Market Size by Application, Type, and Geography: Foreca …
USA, New Jersey- According to Market Research Intellect, the global Urinalysis Strips market in the Internet, Communication and Technology category is projected to witness significant growth from 2025 to 2032. Market dynamics, technological advancements, and evolving consumer demand are expected to drive expansion during this period.
The market for urinalysis strips is steadily growing due to the rising incidence of renal disorders, diabetes, and urinary tract infections (UTIs). The ease of…
Urinalysis Test Market Size and Forecast
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- The global Urinalysis Test Market is expected to record a CAGR of XX.X% from 2024 to 2031 In 2024, the market size is projected to reach a valuation of USD XX.X Billion. By 2031 the valuation is anticipated to reach USD XX.X Billion.
Urinalysis Test Market Definition, With Current Market Values
The urinalysis test market encompasses the development, production, and distribution of diagnostic products and services used to analyze…
Urinalysis Market Demand for Urinalysis Is Expected To Provide Opportunities for …
Urinalysis Market Outlook 2022-2029
The Urinalysis Market research offers complete knowledge and information on the market's flowing landscape, what is now available on the market, upcoming trends, market expectations, the competitive environment, and methods that may be used to outperform competitors.
Market Analysis and Size
The global urinalysis market is expected to grow at more than 7.2% CAGR from 2022 to 2029. It is expected to reach above USD 6.1 billion by 2029…
Urinalysis Market
A urinalysis is a test that measures elements found in urine, such as electrolytes, hormones, or waste products of metabolism. It is also called urine test and involves a number of tests to detect and measure various compounds that pass through the urine. This examination can help find problems that need treatment, including infections or kidney problems. A urine test includes three parts namely, visual exam, microscopic exam, and dipstick…
Urinalysis Market
A urinalysis is a test that measures elements found in urine, such as electrolytes, hormones, or waste products of metabolism. It is also called urine test and involves a number of tests to detect and measure various compounds that pass through the urine. This examination can help find problems that need treatment, including infections or kidney problems. A urine test includes three parts namely, visual exam, microscopic exam, and dipstick…
